Tapewire

Nasdaq · USD

ACHC

Acadia Healthcare Company, Inc.

Export transactions ↓
Tapewire entity
4312
SEC CIK
0001520697
Parsed reports
348

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2025 Filed Feb 28, 2025 22:56 UTC
Farley BrianEVP, GC and Secretary
GrantCommon Stock 2,530 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-030197 · ownership.xml · nonDerivative · entry 1

Farley Brian · CIK 0001576728 · EVP, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,416

F1 · shares: Shares earned based on 2024 performance under performance vesting restricted stock units awarded on July 26, 2023. The shares will not be issued until the end of the three-year period under the restricted stock unit award.

Read SEC document
February 27, 2025 Filed Feb 28, 2025 22:56 UTC
HUNTER CHRISTOPHER H.Director · Chief Executive Officer
Tax withholdingCommon Stock 16,995 $40.26 $684,218.70
Disclosure

SEC source: 0000950170-25-030196 · ownership.xml · nonDerivative · entry 3

HUNTER CHRISTOPHER H. · CIK 0001595519 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,761

Read SEC document
February 27, 2025 Filed Feb 28, 2025 22:56 UTC
HUNTER CHRISTOPHER H.Director · Chief Executive Officer
GrantCommon Stock 13,124 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-030196 · ownership.xml · nonDerivative · entry 2

HUNTER CHRISTOPHER H. · CIK 0001595519 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,756

F2 · shares: Shares earned based on 2024 performance under performance vesting restricted stock units awarded on May 9, 2023. The shares will not be issued until the end of the three-year period under the restricted stock unit award.

Read SEC document
February 27, 2025 Filed Feb 28, 2025 22:56 UTC
HUNTER CHRISTOPHER H.Director · Chief Executive Officer
GrantCommon Stock 6,672 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-030196 · ownership.xml · nonDerivative · entry 1

HUNTER CHRISTOPHER H. · CIK 0001595519 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,632

F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on April 11, 2022.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 22:06 UTC
Khan NasserChief Operating Officer
Tax withholdingCommon Stock 405 $42.49 $17,208.45
Disclosure

SEC source: 0000950170-24-124222 · ownership.xml · nonDerivative · entry 2

Khan Nasser · CIK 0002024642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,546

Read SEC document
September 30, 2024 Filed Nov 8, 2024 22:06 UTC
Khan NasserChief Operating Officer
Tax withholdingCommon Stock 730 $63.28 $46,194.40
Disclosure

SEC source: 0000950170-24-124222 · ownership.xml · nonDerivative · entry 1

Khan Nasser · CIK 0002024642 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,951

Read SEC document
July 26, 2024 Filed Jul 29, 2024 21:01 UTC
Farley BrianEVP, GC and Secretary
Tax withholdingCommon Stock 1,239 $65.06 $80,609.34
Disclosure

SEC source: 0000950170-24-087346 · ownership.xml · nonDerivative · entry 1

Farley Brian · CIK 0001576728 · EVP, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,886

Read SEC document
July 25, 2024 Filed Jul 29, 2024 21:01 UTC
Dixon Heather BrianneChief Financial Officer
Tax withholdingCommon Stock 2,902 $66.28 $192,344.56
Disclosure

SEC source: 0000950170-24-087347 · ownership.xml · nonDerivative · entry 1

Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,017

Read SEC document
June 26, 2024 Filed Jun 28, 2024 21:01 UTC
Farley BrianEVP , GC and Secretary
GrantCommon Stock 10,445 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-079131 · ownership.xml · nonDerivative · entry 1

Farley Brian · CIK 0001576728 · EVP , GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,125

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning June 26, 2025.

Read SEC document
June 26, 2024 Filed Jun 28, 2024 21:01 UTC
Dixon Heather BrianneChief Financial Officer
GrantCommon Stock 15,447 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-079132 · ownership.xml · nonDerivative · entry 1

Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,919

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning June 26, 2025.

Read SEC document
June 26, 2024 Filed Jun 28, 2024 21:01 UTC
HUNTER CHRISTOPHER H.Director · Chief Executive Officer
GrantCommon Stock 37,516 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-079130 · ownership.xml · nonDerivative · entry 1

HUNTER CHRISTOPHER H. · CIK 0001595519 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,960

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning June 26, 2025.

Read SEC document
May 23, 2024 Filed May 28, 2024 23:06 UTC GrantCommon Stock 2,414 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065511 · ownership.xml · nonDerivative · entry 1

Fucci Michael · CIK 0001830184 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,789

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.

Read SEC document
May 23, 2024 Filed May 28, 2024 23:00 UTC
WAUD REEVE BDirector
GrantCommon Stock 3,651 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065502 · ownership.xml · nonDerivative · entry 2

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,283

F2 · shares: Reflects Mr. Waud's election to receive his annual cash retainer as a director for 2024 in shares of common stock.

Read SEC document
May 23, 2024 Filed May 28, 2024 23:00 UTC
WAUD REEVE BDirector
GrantCommon Stock 2,414 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065502 · ownership.xml · nonDerivative · entry 1

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,632

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.

Read SEC document
May 23, 2024 Filed May 28, 2024 23:03 UTC GrantCommon Stock 2,414 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065506 · ownership.xml · nonDerivative · entry 1

Bissell E. Perot · CIK 0001420194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,623

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.

Read SEC document
May 23, 2024 Filed May 28, 2024 23:07 UTC GrantCommon Stock 2,414 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065512 · ownership.xml · nonDerivative · entry 1

GRIECO WILLIAM · CIK 0001248557 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,454

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.

Read SEC document
May 23, 2024 Filed May 28, 2024 18:55 UTC GrantCommon Stock 2,414 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065499 · ownership.xml · nonDerivative · entry 1

Miquelon Wade D · CIK 0001365176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,488

F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning May 23, 2025.

Read SEC document
May 23, 2024 Filed May 28, 2024 23:00 UTC GrantCommon Stock 2,414 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065503 · ownership.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,265

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.

Read SEC document
May 23, 2024 Filed May 28, 2024 23:10 UTC GrantCommon Stock 2,414 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065516 · ownership.xml · nonDerivative · entry 1

Harris Patrice A · CIK 0001827502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,551

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.

Read SEC document
May 23, 2024 Filed May 28, 2024 23:10 UTC GrantCommon Stock 1,539 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065514 · ownership.xml · nonDerivative · entry 2

Bernhard Jason · CIK 0001798185 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,389

F2 · shares: Reflects Mr. Bernhard's election to receive his annual cash retainer as a director for 2024 in shares of common stock.

Read SEC document
May 23, 2024 Filed May 28, 2024 23:10 UTC GrantCommon Stock 2,414 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-065514 · ownership.xml · nonDerivative · entry 1

Bernhard Jason · CIK 0001798185 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,850

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.

Read SEC document
May 23, 2024 Filed May 31, 2024 20:21 UTC GrantCommon Stock 2,414 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-067344 · ownership.xml · nonDerivative · entry 1

KELLY RALPH DAVID · CIK 0001632674 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,072

F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025.

Read SEC document
May 09, 2024 Filed May 10, 2024 17:23 UTC
Hollinsworth John S.EVP of Operations
Tax withholdingCommon Stock 525 $66.06 $34,681.50
Disclosure

SEC source: 0000950170-24-057973 · ownership.xml · nonDerivative · entry 1

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,309

Read SEC document
May 09, 2024 Filed May 10, 2024 21:21 UTC
HUNTER CHRISTOPHER H.Director · Chief Executive Officer
Tax withholdingCommon Stock 1,899 $66.06 $125,447.94
Disclosure

SEC source: 0000950170-24-057972 · ownership.xml · nonDerivative · entry 1

HUNTER CHRISTOPHER H. · CIK 0001595519 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,444

Read SEC document
April 23, 2024 Filed Apr 24, 2024 17:01 UTC
Hollinsworth John S.EVP of Operations
Tax withholdingCommon Stock 552 $70.26 $38,783.52
Disclosure

SEC source: 0000950170-24-047693 · ownership.xml · nonDerivative · entry 1

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,834

Read SEC document
April 11, 2024 Filed Apr 15, 2024 17:01 UTC
Hollinsworth John S.EVP of Operations
Tax withholdingCommon Stock 496 $75.80 $37,596.80
Disclosure

SEC source: 0000950170-24-044485 · ownership.xml · nonDerivative · entry 1

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,386

Read SEC document
April 11, 2024 Filed Apr 15, 2024 21:01 UTC
HUNTER CHRISTOPHER H.Director · Chief Executive Officer
Tax withholdingCommon Stock 1,485 $75.80 $112,563.00
Disclosure

SEC source: 0000950170-24-044484 · ownership.xml · nonDerivative · entry 1

HUNTER CHRISTOPHER H. · CIK 0001595519 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,343

Read SEC document
March 24, 2024 Filed Mar 26, 2024 17:01 UTC
Hollinsworth John S.EVP of Operations
Tax withholdingCommon Stock 2,803 $76.49 $214,401.47
Disclosure

SEC source: 0000950170-24-036540 · ownership.xml · nonDerivative · entry 1

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,882

Read SEC document
March 05, 2024 Filed Mar 6, 2024 17:30 UTC SaleCommon Stock 2,203 $85.39 $188,114.17
Disclosure

SEC source: 0000950170-24-027357 · ownership.xml · nonDerivative · entry 1

Miquelon Wade D · CIK 0001365176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,074

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.25 to $85.50, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 04, 2024 Filed Mar 6, 2024 22:28 UTC SaleCommon Stock 2,500 $85.56 $213,900.00
Disclosure

SEC source: 0000950170-24-027348 · ownership.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,851

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.50 to $85.62, inclusive. The reporting personundertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, fullinformation regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 18:14 UTC
Hollinsworth John S.EVP of Operations
Tax withholdingCommon Stock 11,495 $83.43 $959,027.85
Disclosure

SEC source: 0000950170-24-024126 · ownership.xml · nonDerivative · entry 4

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,685

Read SEC document
February 28, 2024 Filed Mar 1, 2024 18:14 UTC
Hollinsworth John S.EVP of Operations
GrantCommon Stock 7,496 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024126 · ownership.xml · nonDerivative · entry 3

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,180

F3 · shares: Shares earned based on 2023 performance under performance vesting restricted stock units awarded on May 9, 2023. The shares will not be issued until the end of the three-year period under the restricted stock unit award.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 18:14 UTC
Hollinsworth John S.EVP of Operations
GrantCommon Stock 6,336 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024126 · ownership.xml · nonDerivative · entry 2

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,684

F2 · shares: Shares earned based on 2023 performance under performance vesting restricted stock units awarded on April 11, 2022. The shares will not be issued until the end of the three-year period under the restricted stock unit award.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 18:14 UTC
Hollinsworth John S.EVP of Operations
GrantCommon Stock 33,718 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024126 · ownership.xml · nonDerivative · entry 1

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,348

F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on April 23, 2021.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 23:22 UTC
Dixon Heather BrianneChief Financial Officer
GrantCommon Stock 21,560 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024132 · ownership.xml · nonDerivative · entry 1

Dixon Heather Brianne · CIK 0001720793 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,472

F1 · shares: Shares earned based on 2023 performance under performance vesting restricted stock units awarded on July 25, 2023. The shares will not be issued until the end of the three-year period under the restricted stock unit award.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 23:19 UTC
Farley BrianEVP , GC and Secretary
GrantCommon Stock 4,680 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024130 · ownership.xml · nonDerivative · entry 1

Farley Brian · CIK 0001576728 · EVP , GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,680

F1 · shares: Shares earned based on 2023 performance under performance vesting restricted stock units awarded on July 26, 2023. The shares will not be issued until the end of the three-year period under the restricted stock unit award.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 23:13 UTC
HUNTER CHRISTOPHER H.Director · Chief Executive Officer
GrantCommon Stock 24,269 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024124 · ownership.xml · nonDerivative · entry 2

HUNTER CHRISTOPHER H. · CIK 0001595519 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,828

F2 · shares: Shares earned based on 2023 performance under performance vesting restricted stock units awarded on May 9, 2023. The shares will not be issued until the end of the three-year period under the restricted stock unit award.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 23:13 UTC
HUNTER CHRISTOPHER H.Director · Chief Executive Officer
GrantCommon Stock 19,822 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024124 · ownership.xml · nonDerivative · entry 1

HUNTER CHRISTOPHER H. · CIK 0001595519 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,559

F1 · shares: Shares earned based on 2023 performance under performance vesting restricted stock units awarded on April 11, 2022. The shares will not be issued until the end of the three-year period under the restricted stock unit award.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 21:14 UTC SaleCommon Stock 35,000 $77.67 $2,718,450.00
Disclosure

SEC source: 0000950170-23-070551 · ownership.xml · nonDerivative · entry 2

OSTEEN DEBRA K · CIK 0001181035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 675,833

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.0203 to $78.47, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 12, 2023 Filed Dec 14, 2023 21:14 UTC SaleCommon Stock 8,000 $76.23 $609,840.00
Disclosure

SEC source: 0000950170-23-070551 · ownership.xml · nonDerivative · entry 1

OSTEEN DEBRA K · CIK 0001181035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 710,833

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.2013 to $76.2501, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 17:01 UTC
Hollinsworth John S.EVP of Operations
SaleCommon Stock 27,500 $74.50 $2,048,750.00
Disclosure

SEC source: 0000950170-23-064559 · ownership.xml · nonDerivative · entry 5

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,630

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.50 to $74.51, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 17:01 UTC
Hollinsworth John S.EVP of Operations
SaleCommon Stock 20,000 $74.00 $1,480,000.00
Disclosure

SEC source: 0000950170-23-064559 · ownership.xml · nonDerivative · entry 4

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,130

Read SEC document
November 14, 2023 Filed Nov 16, 2023 17:01 UTC
Hollinsworth John S.EVP of Operations
SaleCommon Stock 15,000 $73.51 $1,102,650.00
Disclosure

SEC source: 0000950170-23-064559 · ownership.xml · nonDerivative · entry 3

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,130

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.50 to $73.68, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 17:01 UTC
Hollinsworth John S.EVP of Operations
SaleCommon Stock 15,000 $73.66 $1,104,900.00
Disclosure

SEC source: 0000950170-23-064559 · ownership.xml · nonDerivative · entry 2

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,130

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.5506 to $73.81, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 17:01 UTC
Hollinsworth John S.EVP of Operations
SaleCommon Stock 15,000 $74.00 $1,110,000.00
Disclosure

SEC source: 0000950170-23-064559 · ownership.xml · nonDerivative · entry 1

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,130

Read SEC document
November 10, 2023 Filed Nov 13, 2023 17:42 UTC
Hollinsworth John S.EVP of Operations
SaleCommon Stock 20,000 $73.00 $1,460,000.00
Disclosure

SEC source: 0000950170-23-063169 · ownership.xml · nonDerivative · entry 2

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,130

Read SEC document
November 10, 2023 Filed Nov 13, 2023 22:46 UTC
WAUD REEVE BDirector
GrantCommon Stock, par value $0.01 per share 68,028 $73.02 $4,967,404.56
Disclosure

SEC source: 0000950170-23-063176 · ownership.xml · nonDerivative · entry 1

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 653,015

F1 · shares: Represents shares purchased by the Halcyon Exempt Family Trust (the "Halcyon Trust").

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.90 to $73.50, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The shares are owned of record as follows: (i) 225,519 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"), (v) 43,643 shares by the Cornelius Byron Waud 2002 Trust (the "2002 CBW Family Trust"), and (vi) 34,500 shares by the Corinna Reeve Waud 2002 Trust ("2002 CRW Family Trust").

F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries, and (D) his being appointed, in June 2023, as the co-trustee of the 2002 CBW Family Trust and the 2002 CRW Family Trust of which Mr. Waud's parents are beneficiaries.

F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

Read SEC document
November 08, 2023 Filed Nov 13, 2023 17:33 UTC SaleCommon Stock 15,000 $74.21 $1,113,150.00
Disclosure

SEC source: 0000950170-23-063149 · ownership.xml · nonDerivative · entry 1

OSTEEN DEBRA K · CIK 0001181035 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 718,833

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.1201 to $74.36, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 08, 2023 Filed Nov 13, 2023 17:42 UTC
Hollinsworth John S.EVP of Operations
SaleCommon Stock 12,500 $74.50 $931,250.00
Disclosure

SEC source: 0000950170-23-063169 · ownership.xml · nonDerivative · entry 1

Hollinsworth John S. · CIK 0001782021 · EVP of Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,130

Read SEC document
October 26, 2023 Filed Oct 27, 2023 21:10 UTC GrantCommon Stock 2,137 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-056055 · ownership.xml · nonDerivative · entry 1

Harris Patrice A · CIK 0001827502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,137

F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning October 26, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.